Parallel Fund Iv, L.P.Ah Pa... Net Worth

The estimated Net Worth of Parallel Fund Iv, L.P.Ah Pa... is at least $14.8 Milión dollars as of 7 July 2020. Parallel Pa owns over 10 units of Accolade stock worth over $14,778,314 and over the last 4 years Parallel sold ACCD stock worth over $220.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Parallel Pa ACCD stock SEC Form 4 insiders trading

Parallel has made over 1 trades of the Accolade stock since 2020, according to the Form 4 filled with the SEC. Most recently Parallel sold 10 units of ACCD stock worth $220 on 7 July 2020.

The largest trade Parallel's ever made was selling 10 units of Accolade stock on 7 July 2020 worth over $220. On average, Parallel trades about 10 units every 0 days since 2020. As of 7 July 2020 Parallel still owns at least 3,779,620 units of Accolade stock.

You can see the complete history of Parallel Pa stock trades at the bottom of the page.

Insiders trading at Accolade

Over the last 4 years, insiders at Accolade have traded over $9,006,680 worth of Accolade stock and bought 74 units worth $743 . The most active insiders traders include Edgar Jr Bronfman, Jeffrey D Jordan a Dawn G Lepore. On average, Accolade executives and independent directors trade stock every 5 days with the average trade being worth of $18,928. The most recent stock trade was executed by Rajeev Singh on 3 September 2024, trading 3,786 units of ACCD stock currently worth $14,803.

What does Accolade do?

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.

Complete history of Parallel Pa stock trades at Accolade

Accolade executives and stock owners

Accolade executives and other stock owners filed with the SEC include:

• Rajeev Singh,
  Chairman & CEO
• Robert Cavanaugh,
  Pres
• Stephen H. Barnes CPA,
  CFO & Treasurer
• Michael W. Hilton,
  Chief Innovation Officer
• Jennifer Hanson,
  Exec. VP of People and Culture & Chief HR Officer
• Britt Provost,
  Exec. VP of People & Culture
• Carolina Lobo,
  Chief Marketing Officer
• Phong Nguyen,
  Chief Operating Officer
• William S. Morrison,
  Sr. VP of Strategy & Corp. Devel.
• Richard Eskew,
  Exec. VP, Gen. Counsel & Chief Privacy Officer
• Todd Friedman,
  Sr. VP of Investor Relations
• Harish Naidu,
  Chief Technology Officer
• David Wyatt,
  Exec. VP of Operations
• Stephen H. Barnes,
  CFO, Treasurer & Sec.
• J. Michael Cline,
  Co-Founder & Independent Chairman
• Dawn G Lepore,
  Director
• Patricia L Wadors,
  Director
• William H. Frist,
  Director
• Jeffrey D Jordan,
  Director
• Thomas J Neff,
  Director
• Capital Partners Ii Co Inve...,
  
• James C. Madden,
  
• Parallel Fund Iv, L.P.Ah Pa...,
  
• Horowitz Fund Iv, L.P.Andre...,
  
• J Michael Cline,
  Director
• Edgar Jr Bronfman,
  
• Rajeev Singh,
  Chief Executive Officer
• Stephen H. Barnes,
  Chief Financial Officer
• Robert N Cavanaugh,
  President
• Cindy Kent,
  Director
• Jeffrey S Brodsky,
  Director
• Elizabeth G Nabel,
  Director
• Peter S Klein,
  Director
• Michael W Hilton,
  Director
• Richard Eskew,
  EVP General Counsel
• Colin Mc Hugh,
  Chief Accounting Officer